A consecutive cohort of 586 Hong Kong Chinese outpatients completed the PHQ-9 during comprehensive diabetes complication assessment. Within 2-4 weeks, 40 patients were retested via telephone survey. Ninety-nine randomly selected patients were interviewed by psychiatrists using the Mini International Neuropsychiatric Interview as a golden standard. Receiver operating characteristic curve was used to assess performance of the PHQ-9.
The internal consistency of the PHQ-9 was 0.86 and test-retest reliability was 0.70. The 3 somatic items explained 53.6 % of the PHQ-9 score. The optimal cutoff value was 7 with 82.6 % sensitivity and 73.7 % specificity, giving a depression prevalence of 18.3 % (n=107). Of these, 18.7 % had been previously diagnosed with depression. Depression was more prevalent in women than men. After controlling for confounders, patients with depression had higher HbA1c (7.80¡À1.86 % versus 7.43¡À1.29 % , [61.7¡À20.4 versus 57.8¡À14.1 mmol/mol], P<0.05), reduced likelihood of achieving HbA1c target of <7.0 % (33.6 % versus 41.8 % , P<0.05), and were more likely to have self-reported hypoglycemia in the previous 3 months (18.7 % versus 6.7 % , P<0.01).
A small sample was used in the criterion validation and the cross-sectional design precludes causal inference.
PHQ-9 is a validated tool for screening for depression, which is common and frequently undiagnosed in Chinese type 2 diabetic patients and is associated with suboptimal glycemic control, hypoglycemia, and somatization.